|
MLTX | Moonlake Immunotherapeutics |
|
|
MLTX | Moonlake Immunotherapeutics |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.61 |
| Leverage | 30.92% |
| Market Cap | $ 1.4B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -256.4m |
| Margin | -1390.86% |
None